Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Do Women Receive Worse Gout Treatment Than Men?

Richard Quinn  |  February 5, 2014

Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease.  (posted Feb. 5)

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Ethics Forum: The Ethical Challenges of Recruiting Patients for Clinical Trials

Carol M. Greco, PhD, and Donah Zack Crawford, MA  |  February 1, 2014

A successful recruiter raises concerns about balancing friendliness and enthusiasm with legal and ethical constraints when screening human subjects for research

Tech Talk: Smartphone Apps, Online Games May Encourage Healthy Behaviors in Rheumatology Patients

Susan Bernstein  |  February 1, 2014

Customized text messages and virtual reality technology can help health professionals prompt patients to take medications and get exercise

Paleopathology Uses Patients from the Past to Investigate Today’s Diseases

Bruce Rothschild, MD  |  February 1, 2014

Evidence of disease in prehistoric skeletons can provide clues to early characteristics of rheumatoid arthritis, calcium pyrophosphate deposition disease, and other joint disorders

2013 ACR/ARHP Annual Meeting: Strides Made in Understanding Systemic Sclerosis

Susan Bernstein  |  February 1, 2014

Greater knowledge of how vasculitis, fibrosis, and autoimmunity interact in these destructive diseases will result in better clinical management

2013 ACR/ARHP Annual Meeting: Inflammatory Eye Disease Management Can Benefit from Collaboration between Rheumatologists and Ophthalmologists

Susan Bernstein  |  February 1, 2014

Joint effort is critical to diagnosing and treating uveitis, iritis, and other autoimmune eye disorders in patients with inflammatory disease

2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed

Susan Bernstein  |  February 1, 2014

New research clarifies signs of rheumatoid arthritis and systemic lupus erythematosus years in advance and could lead to presymptomatic treatment intervention

2013 ACR/ARHP Annual Meeting: Research Provides Insight into Preclinical Rheumatic Disease

Mary Beth Nierengarten  |  February 1, 2014

Data offer clues to role of mucosal biology in etiology of rheumatoid arthrits and early pathology of rheumatic diseases

2013 ACR/ARHP Annual Meeting: Diagnostic,Treatment Approaches Evolve for Kawasaki Disease

Mary Beth Nierengarten  |  February 1, 2014

New data examine infliximab as a treatment option, and updated diagnostic criteria aids physicians in recognizing KD and detecting cardiac involvement in patients

  • « Previous Page
  • 1
  • …
  • 630
  • 631
  • 632
  • 633
  • 634
  • …
  • 815
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences